Biomarkers Improve Cost-Benefit Analysis of Head and Neck Cancer Immunotherapy
A new economic analysis suggests that the value of pembrolizumab for patients with locally advanced head and neck squamous cell ...
A new economic analysis suggests that the value of pembrolizumab for patients with locally advanced head and neck squamous cell ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine